Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000821250 | SCV000962003 | uncertain significance | Glucose-6-phosphate transport defect | 2023-11-29 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 335 of the SLC37A4 protein (p.Gly335Glu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with glycogen storage disease (PMID: 32374048). ClinVar contains an entry for this variant (Variation ID: 663384). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC37A4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV000821250 | SCV001806731 | uncertain significance | Glucose-6-phosphate transport defect | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001579263 | SCV001806732 | uncertain significance | Phosphate transport defect | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002275158 | SCV002563087 | uncertain significance | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | SLC37A4: PM2, PP3 |
Natera, |
RCV000821250 | SCV002078674 | uncertain significance | Glucose-6-phosphate transport defect | 2020-07-23 | no assertion criteria provided | clinical testing |